Open Access

What is the evidence supporting the new valvular heart disease (VHD) guidelines regarding severe aortic stenosis (AS) treatment?

Presentation

About the speaker

Professor Helge Moellmann

St. Johannes-Hospital, Dortmund (Germany)
10 presentations
0 follower

3 more presentations in this session

New VHD guidelines – What are the implications for the cardiologist?

Speaker: Professor H. Moellmann (Dortmund, DE)

Thumbnail

New VHD guidelines – What are the implications for transcatheter aortic valve implantation (TAVI) implanters?

Speaker: Professor H. Moellmann (Dortmund, DE)

Thumbnail

Summary: key learnings and conclusion - How the new European VHD guidelines could change the treatment of AS patients?

Speaker: Professor H. Moellmann (Dortmund, DE)

Thumbnail

Access the full session

How the new European valvular heart disease guidelines could change the treatment of AS patients?

Speakers: Professor H. Moellmann, Professor H. Moellmann, Professor H. Moellmann, Professor H. Moellmann
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk